PozeSCAF

Loading proteins…

Your discovery partner

Your program.
Our integrated
expertise.

PozeSCAF is a preclinical drug discovery CRO and scientific partner supporting programs from target identification and validation through hit discovery, lead optimization, and candidate selection.

Engage us for a focused scientific challenge or an integrated discovery program—with computational scientists, medicinal chemists, and biologists working together around your objectives.

Three disciplines. One discovery team.

AI & Computational Drug Discovery

AxDrug™ combines disease and target intelligence, generative AI, and virtual screening to identify and prioritize chemical matter.

Physics-based modeling and molecular simulation guide design, while predictive models assess ADMET properties and potential off-target liabilities.

Explore AxDrug™ →

Medicinal Chemistry & Synthesis

Structure-guided medicinal chemistry translates design hypotheses into compounds ready for experimental testing.

Our team develops synthetic routes, synthesizes and characterizes molecules, and builds structure–activity relationships to guide potency, selectivity, and developability.

Explore Medicinal Chemistry & Synthesis →

In Vitro Biology

Target-specific biochemical and cell-based assays measure compound activity and biological response.

Target-engagement and functional studies help evaluate mechanism, potency, and selectivity—generating experimental feedback for the next design cycle.

Explore In Vitro Biology →

Integrated discovery engine

AxDrug™ — Intelligence
Connected to Experiment

One connected workflow linking disease biology, generative design, molecular physics, predictive developability, and experimental feedback.

  1. 01

    Understand

    KG-SCAF
    Disease biology
    Target validation

  2. 02

    Design

    Generative AI
    Medicinal chemistry
    Modality design

  3. 03

    Evaluate

    Docking
    MD · FEP
    QM/MM

  4. 04

    Make

    MedChem
    Synthesis
    Peptide chemistry

  5. 05

    Test

    Biochemical
    Cellular
    ADME

  6. 06

    Learn

    SAR
    Active learning
    Next DMTA cycle

THERAPEUTIC MODALITIES

DISCOVERY CHALLENGES WE ADDRESS

Complex targets.
Clear next experiments.

Connecting molecular insight with design decisions and experimental testing.

Conceptual protein pocket with an approaching molecule
01 / DIFFICULT TARGETS

Find the hidden pocket.

Explore protein flexibility and transient pockets to guide molecular design, prioritize potential hits, and plan experimental testing.

Pocket exploration → Design → Testing
Conceptual comparison of two different binding pockets
02 / SELECTIVITY

Design for selectivity.

Compare related binding environments and combine molecular modeling, medicinal chemistry, and experimental feedback to investigate differentiation.

Potency + Selectivity + Developability
Conceptual molecular bridge bringing two proteins together
03 / ADVANCED MODALITIES

Bring proteins together.

Explore ternary-complex geometry, linker design, and molecular interactions to guide proximity-driven strategies and functional testing.

Structure → Design → Functional testing

FEW OF OUR CLIENTS

PennState college of medicine
TGen
Stingray Therapeutics

Connect with our team · 2026

Meet PozeSCAF

Meet us at upcoming industry events to discuss AI-enabled drug discovery, medicinal chemistry, synthesis and in vitro biology.

PozeSCAF upcoming events, September–November 2026
Event Dates · 2026 Location
Discovery on Target – Boston, USA
BioJapan – Yokohama, Japan
Precision Drug Discovery, Preclinical & Manufacturing Summit – San Diego, USA
Covalent Drug Discovery & Development Summit – Boston, USA
Drug Discovery Chemistry Europe – Barcelona, Spain
US Biotech Day – Philadelphia, USA
Discuss your drug discovery challenges with PozeSCAF
Reach Out and Accelerate Your Drug Discovery with Integrated AxDrug, Synthesis, and In Vitro Biology.